Results 131 to 140 of about 40,013 (196)

Deep intronic <i>MSH2</i> variant confirms Muir-Torre subtype of Lynch syndrome. [PDF]

JID Innov
Chan-Pak-Choon F, Shuen AY, Weber E, Fu L, Rivera B, Foulkes WD.   +5 more
europepmc   +1 more source

Synchronous triple cancers of synchronous endometrial and ovarian carcinoma complicated by renal cancer: a case report. [PDF]

Front Oncol
Xu M, Fu J, Cai L.
europepmc   +1 more source

An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed. [PDF]

Ther Adv Med Oncol
Fanale D, Magrin L, Corsini LR, Pedone E, Brando C, Bazan Russo TD, Ferraro P, Carobene K, Cipolla EA, Colletta G, Puglisi M, Galvano A, Vieni S, Pantuso G, Giannone AG, Badalamenti G, Incorvaia L, Russo A, Bazan V.   +18 more
europepmc   +1 more source

Recurrent Pituitary Adenoma Causing Cushing's Disease in a Patient With Lynch Syndrome. [PDF]

Cureus
Bares V, Netuka D.
europepmc   +1 more source

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma. [PDF]

ESMO Open
Altieri B, Kircher S, Herterich S, Jahn A, Teleanu MV, Lippert J, Landwehr LS, Kimpel O, Reuter M, Remde H, Stenzinger A, Glimm H, Bargou RC, Fröhling S, Ronchi CL, Appenzeller S, Fassnacht M, Kroiss M.   +17 more
europepmc   +1 more source

Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutation. [PDF]

J Clin Invest
Li A, Sears TK, Horbinski CM.
europepmc   +1 more source

NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cells. [PDF]

Int J Biol Sci
Radom M, Buffet C, Cazarin J, Harinquet M, de Faria CC, Brayé F, Nobre C, Aglave M, Mesloub Y, Dayris T, Droin N, Godefroy K, Bani MA, Ghuzlan AA, Leboulleux S, Lamartina L, Dupuy C.   +16 more
europepmc   +1 more source

A common food mutagen promotes intestinal carcinogenesis by multiple mechanisms in mouse models of Lynch syndrome. [PDF]

NAR Cancer
Rayner E, Tsaalbi-Shtylik A, Marques L, Agaser C, Mei H, Cats D, van Zanen-Gerhardt S, Salvatori D, de Wind N.   +8 more
europepmc   +1 more source

The gut microbiome as a biomarker and modifiable risk factor in Lynch Syndrome. [PDF]

Fam Cancer
Colaco VS, Boleij A.
europepmc   +1 more source

Utilization of care and alignment of screening with NCCN guidelines for patients with Lynch syndrome: a retrospective cohort study. [PDF]

Hered Cancer Clin Pract
Lowry C, Laurent C, Bindra AK, Powell CB, Garcia C.   +4 more
europepmc   +1 more source